CVS Health launches new brand Cordavis to target $100 billion biosimilar market
CVS Health (CVS) on Wednesday announced the launch of a new business unit, Cordavis, to bring private label biosimilar drugs to market. Prem Shah, EVP and chief pharmacy officer at CVS, told Yahoo Finance the […]